Statement highlights:
People with cardiovascular abnormalities have previously been considered unqualified for competitive sports participation, but new evidence shows that athletes of all ages with a particular cardiac abnormality or illness are more competitive It shows you may be safe to participate in sports. The new joint scientific statement from the American Heart Association and the American College of Cardiology highlights the need for common decision-making between athletes and their clinicians, as they consider competitive sports participation for people. Provide guidance to healthcare professionals on how to assess risks. Various cardiovascular conditions. To better understand how competitive sports participation affects the overall health of athletes with cardiovascular abnormalities and how social disparities affect competitive athletes requires more research.
It is prohibited until 4am (5am) on Thursday, February 20th, 2025
Dallas and Washington, February 20, 2025 – A recent survey revealed that a potential scientific statement revealed cardiovascular abnormalities after sharing decisions with clinicians, according to a joint scientific statement released today. It has been suggested that some athletes with the game can safely participate in competitive sports. The flagship of the American Heart Association, the American Heart Association’s flagship journal, and the JACC is also the flagship journal of the American Faculty of Cardiology.
The new scientific statement, “Clinical Considerations for Competitive Sports Participation in Athletes with Cardiovascular Impairments,” includes significant changes based on evidence from the past decade. Previous scientific statements were published in 2015.
“In the past, no decisions were shared about sports eligibility for heart disease athletes. Jonathan H. Kim, MD, FACC, Associate Professor of Medicine and Director of Sports Psychology at Emory University School. Jonathan H. Kim, writing group for M.Sc., said: “This new scientific statement is the best for athletes with specific cardiovascular conditions. We review how clinical practices and how healthcare professionals can guide these athletes, from these to master athletes, in a shared discussion of decision-making about potential risks and rewards.”
The change in message reflects the advances in the medical community’s understanding of the “athlete mind” that captures complex structural, functional and electrical cardiac adaptations that occur in response to habitual exercise training. Research over the past decade on many cardiac conditions, ranging from congenital heart disease to arrhythmias, shows that risks are not as high as previously thought during sports participation, and potential outcomes for many athletes. .
Previous scientific statements have categorized sports into specific categories, but this revision acknowledges that sports training is dynamic. This is a series of athlete-specific strength and endurance. Consider that not all athletes train the same way, not all sports are similar, and not all heart conditions pose the same risk. The Writing Group defined competitive athletes as professional athletes who have achieved a high premium in their achievements and training to compete not only in team sports such as marathons and triathlons, but also in individual sports.
This new scientific statement is aimed at athletes not included in previous documents. For example, there is a section dedicated to assessing the risk of master athletes (people over 35) with coronary artery disease, atrial fibrillation, aortic enlargement, and valve disease. We also have the latest information on extreme sports athletes, such as those engaged in scuba diving and high altitude exercise. The statement also provides a way to provide better information about potential risks to healthy people who want to play competitive sports during pregnancy, given the significant changes in physical and metabolic conditions brought about by pregnancy. It also explains.
“We acknowledge that the risk of competition can be much higher than the benefits of athletes with cardiovascular abnormalities,” Kim said.
New evidence will be notified of updates
This statement reinforces the importance of pre-participation cardiac screening for school-age athletes. Medical professionals should start with a 14-point assessment from the association. This includes physical examinations with blood pressure measurements and questions about family and individual health history. Electrocardiograms (ECGs) (tests that measure electrical activity in the heart) are also a reasonable screening of asymptomatic athletes, as long as appropriate expertise in ECG interpretation of motor skills is provided. Additionally, all athletes in the screening program should have access to equitable resources for subsequent clinical evaluation of abnormal ECGs. For athletes taking blood thinning medications, the new statement provides more guidance on how healthcare professionals can assess risk based on a particular type of sport . Certain activities that are at high risk of trauma and bleeding, such as soccer, competitive cycling, outdoor skiing, and baseball, should be considered in athletes taking blood thinning medications. Previously, when people with cardiomyopathy (when the myocardium expands, thickens or stiffens) were told not to compete in sports, the author of this update did not apply the unified commission of sports restrictions. please. Participation in sports may be reasonable in some genetic cardiomyopathies. Previous recommendations for people with myocarditis were that they should not participate in sports for 3-6 months. However, this is because it was based solely on expert opinions and there was no data to support it. In the current study, this condition (inflammation of the central muscle layer of the heart wall) often improves within three months, so many of these athletes are safer and more competitive than previously thought. It has been suggested that there is a possibility of returning to a certain sport. Individual assessments and clinical guidance are always required in this setting. According to a new statement, not all young athletes in the aorta, or all young athletes with aortic abnormalities, should be encouraged to restrict participation in the sport. The manuscript provides details on how to evaluate athletes by expanding the aorta. This statement addresses genetic cardiac rhythm disorder catecholaminergic polymorphism ventricular tachycardia. Competitive sports can be considered for athletes who receive appropriate professional care in stratification of clinical risk.
Knowledge gaps and future research needs
Researchers and healthcare professionals provide more information on how athletes with cardiovascular disease progress during ongoing sports participation if sports participation improves or harms overall health. I need it. The Cardiac Condition Results Registry in Athlete (ORCCA) Research, Founded in May 2020, is the first prospective, multi-purpose design designed to monitor clinical outcomes of athletes with potentially threatened cardiovascular conditions. Institutional, longitudinal, observational cohort study. It is designed to better understand the myriad outcomes after a disease diagnosis and includes a diverse population of athletes with cardiovascular disease. The American Medical Association, the American Heart Association, and the UW Sports Heart Center support the ORCCA.
Furthermore, there is a major gap in the information on competitive athletes with cardiovascular conditions affected by social disparities in health.
“When I see the risk of sudden cardiac death in young athletes, I know that young black athletes look at high risk, but I don’t know why,” Kim said. “Social disparities are a very reasonable hypothesis to believe that disparities play an important role in athletes’ health outcomes, as are people in the general population, so we must look at social disparities. It won’t happen.”
This scientific statement is based on the review of Clinical Cardiopathology Board, Basic Cardiovascular Science Council, Cardiovascular and Stroke Nursing Council, Cardiovascular Surgery Council, Anesthesia, Anesthesia Council, Peripheral Vascular Diseases and American College of Cardiology Meeting. Scientific statements can help promote greater awareness about cardiovascular disease and stroke issues and promote informed health care decisions. The scientific statement outlines what is currently known about the topic and areas where additional research is needed. Scientific statements inform the development of guidelines but do not recommend treatment. The American Heart Association guidelines provide recommendations for the association’s official clinical practice.
Co-authors are co-chairs Aaron L. Bagish, MD, and FACC. Co-chairman Benjamin D. Levine, MD, FAHA, FACC; Michael J. Ackerman, MD, Ph.D., FACC; Sharlene M. Day, MD, Faha; Elizabeth H. Dinneen, do, facc; J. Sawaragse II, MD; Andre La Gerche, MBBS, Ph.D. ;Rachel Lampert, MD, FACC;Matthew W. Martinez, MD, FACC;Michael Papadakis, MBBS, MD;Dermot M. Phelan, MD, Ph.D., FACC;Kerri M. Schafer, MD, FACC. Author disclosures are listed in the manuscript.
Associations receive funds primarily from individuals. Foundations and businesses (including drugs, device manufacturers and other companies) also make donations to fund specific association programs and events. The Association has strict policies to prevent these relationships from affecting the content of science. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers, as well as the association’s overall financial information can be found here.
Additional resources:
About the American Heart Association
The American Heart Association is a relentless force for a longer, healthier world of living. Dedicated to ensuring equitable health across all communities, the organization has been a leading source of health information for over 100 years. Supported by more than 35 million volunteers worldwide, we fund groundbreaking research, advocate for national health, save lives affected by cardiovascular disease and stroke; It provides important resources to improve. By driving breakthroughs and implementing proven solutions in science, policy and care, we work tirelessly to promote health and change our lives every day. Connect via heart.org, facebook, x or call 1-800-aha-usa1.
About the American College of Cardiology
The American College of Cardiology (ACC) is a global leader in transforming cardiovascular care and improving heart health for all. Since 1949, as an outstanding source of specialist medical education across the cardiovascular care team, ACC qualifications have been established with over 140 cardiovascular experts who meet strict qualifications and lead the formation of health policies, standards and guidelines. I’m acknowledging it. Through the JACC Journal’s world-renowned families, NCDR registry, ACC accredited services, a global network of member sections, cardiac patient resources, and more, the university ensures a world where science, knowledge and innovation optimize patient care and outcomes I’m working on it. For more information, follow www.acc.org or @accintouch.
For media enquiries: 214-706-1173
American Heart Association: Amanda Ebert, amanda.ebert@heart.org
American Faculty of Cardiology: Olivia Walther, owalther@acc.org
Public inquiry: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org
